REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)
Clinical trial NCT04523428 · RECRUITING
Trial details
- NCT number
- NCT04523428
- Sponsor
- Stichting Hemato-Oncologie voor Volwassenen Nederland
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-23
- Primary completion
- 2028-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.